MAVERICK
Dead / Cancelled — Cancelled — Section 8 (as of 15 Nov 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86971654
- Registration number
- 5459564
- Mark type
- Stylized text
- Filed
- 11 Apr 2016
- Published for opposition
- 12 Jul 2016
- Registered
- 01 May 2018
- Attorney of record
- Christine K. Au-Yeung
Goods and services
- Class 042 — Scientific and technological services: Medical and pharmaceutical research services in the field of cancer; medical and pharmaceutical research services; pharmaceutical research and development in the field of cancer; pharmaceutical research and development; research, development, and testing services in the fields of pharmaceutical and biotechnology products; drug discovery, research, and development in the pharmaceutical and biotechnology fields
- Class 044 — Medical, beauty and agricultural services: Medical diagnosis and treatment of cancer; providing information in the field of cancer diagnosis and treatment; providing healthcare and medical information
Owner
- TAKEDA PHARMACEUTICALS U.S.A., INC., LEXINGTON, MA, US
- MAVERICK THERAPEUTICS, INC., BRISBANE, CA, US
- MAVERICK THERAPEUTICS, INC., BRISBANE, CA, US
- Harpoon Therapeutics, Inc., Brisbane, CA, US
- Harpoon Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 15 Nov 2024 — CANCELLED SEC. 8 (6-YR)
- 01 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jan 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Feb 2018 — USE AMENDMENT FILED
- 01 Mar 2018 — SOU EXTENSION 3 GRANTED
- 23 Feb 2018 — SOU EXTENSION 3 FILED
- 26 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Feb 2018 — SOU TEAS EXTENSION RECEIVED
- 23 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 29 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED